1. Home
  2. MYI vs SGP Comparison

MYI vs SGP Comparison

Compare MYI & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniYield Quality Fund III Inc

MYI

Blackrock MuniYield Quality Fund III Inc

N/A

Current Price

$10.84

Market Cap

728.5M

Sector

Finance

ML Signal

N/A

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$26.41

Market Cap

650.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYI
SGP
Founded
N/A
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
728.5M
650.9M
IPO Year
1994
2026

Fundamental Metrics

Financial Performance
Metric
MYI
SGP
Price
$10.84
$26.41
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$45.00
AVG Volume (30 Days)
250.9K
73.2K
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.35
$17.06
52 Week High
$11.46
$30.56

Technical Indicators

Market Signals
Indicator
MYI
SGP
Relative Strength Index (RSI) 49.32 72.54
Support Level $10.82 $25.25
Resistance Level $11.10 $27.23
Average True Range (ATR) 0.09 1.36
MACD 0.02 0.28
Stochastic Oscillator 67.76 100.00

Price Performance

Historical Comparison
MYI
SGP

About MYI Blackrock MuniYield Quality Fund III Inc

BLACKROCK MUNIYIELD QUALITY FUND III, INC. is an investment management company. Its investment objective is to provide shareholders with a high level of current income exempt from U.S. federal income taxes, as is consistent with its investment policies and prudent investment management. The fund invests a majority of its assets in municipal obligations exempt from U.S. federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax). Under normal market conditions, the fund invests mainly in long-term municipal obligations that are investment-grade quality or are considered by the adviser to be of comparable quality at the time of investment. It can also invest directly in such securities or synthetically through the use of derivatives.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: